Both Tesaro Inc. (NASDAQ:TSRO) and Intec Pharma Ltd. (NASDAQ:NTEC) compete on a level playing field in the Biotechnology industry. We will evaluate their performance with regards to profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation.
Table 1 shows top-line revenue, earnings per share and valuation of the two companies.
Table 2 has Tesaro Inc. and Intec Pharma Ltd.’s return on assets, return on equity and net margins.
Tesaro Inc. and Intec Pharma Ltd. Ratings and Recommendations are available on the next table.
Tesaro Inc.’s downside potential currently stands at -12.25% and an $65.78 consensus price target.
Insider Institutional Ownership
Institutional investors held 0% of Tesaro Inc. shares and 40.62% of Intec Pharma Ltd. shares. Insiders held 0.1% of Tesaro Inc. shares. Competitively, 11.4% are Intec Pharma Ltd.’s share held